SGLT 2 INHIBITORS
Clinical trials for SGLT 2 INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new SGLT 2 INHIBITORS trials appear
Sign up with your email to follow new studies for SGLT 2 INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug shows promise in fighting advanced cancers
Disease control Not yet recruitingThis trial investigates whether canagliflozin, a diabetes drug, can be safely combined with the immunotherapy tislelizumab to treat advanced solid tumors. The study includes adults with unresectable, recurrent, or metastatic cancers who have not responded to standard treatments. …
Matched conditions: SGLT 2 INHIBITORS
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Diabetes pill may reverse early heart damage, small study suggests
Disease control Not yet recruitingThis study looks at whether common diabetes drugs called SGLT2 inhibitors (like empagliflozin and dapagliflozin) can improve the structure and function of the heart's left atrium in people with type 2 diabetes. Researchers will use advanced ultrasound to measure heart changes in …
Matched conditions: SGLT 2 INHIBITORS
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC